−3.74SEK
−128.30 MSEK
638.80 MSEK
19.60 M
About OREXO AB
Sector
CEO
Nikolaj Sørensen
Headquarters
Uppsala
Website
Employees (FY)
116
Founded
1994
ISIN
SE0000736415
FIGI
BBG000R0CCS9
Orexo AB engages in the development of pharmaceuticals based on innovative drug delivery technologies. It operates through the following segments: US Pharma, Digital Therapeutics (DTx), and HQ and Pipelines. The US Pharma segment include sales of own pharmaceuticals in the US. The DTx segment comprises digital therapeutic venture. The HQ and Pipeline segment focuses in the out-licensed pharmaceuticals and costs for research and development, business development, global regulatory, and supply chain. The company was founded by Thomas Lundqvist on November 18, 1994 and is headquartered in Uppsala, Sweden.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of ORX is 16.92 SEK — it has increased by 3.30% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on OMXSTO exchange OREXO AB stocks are traded under the ticker ORX.
OREXO AB is going to release the next earnings report on May 8, 2024. Keep track of upcoming events with our Earnings Calendar.
ORX earnings for the last quarter are −0.97 SEK whereas the estimation was −0.92 SEK which accounts for −5.43% surprise. Estimated earnings for the next quarter are −0.47 SEK. See more details about OREXO AB earnings.
OREXO AB revenue for the last quarter amounts to 156.10 M SEK despite the estimated figure of 154.30 M SEK. In the next quarter revenue is expected to reach 150.40 M SEK.
Yes, you can track OREXO AB financials in yearly and quarterly reports right on TradingView.
Like other stocks, ORX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade OREXO AB stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 16, 2024, the company has 116.00 employees. See our rating of the largest employees — is OREXO AB on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. OREXO AB EBITDA is −46.60 M SEK, and current EBITDA margin is −7.14%. See more stats in OREXO AB financial statements.